Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/17/2009CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009CA2727669A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
12/17/2009CA2727627A1 Use of histamine h4 antagonist for the treatment of post-operative adhesions
12/17/2009CA2727620A1 Tricyclic indole derivatives and methods of use thereof
12/17/2009CA2727617A1 Smoking cessation kit and method
12/17/2009CA2727607A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
12/17/2009CA2727595A1 Thiazole compounds, and compositions and methods using same
12/17/2009CA2727594A1 Novel polymorphic forms of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid
12/17/2009CA2727587A1 Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid
12/17/2009CA2727561A1 Dihydrotetrabenanzine for the treatment of anxiety
12/17/2009CA2727546A1 Methods of treatment of bipolar disorder
12/17/2009CA2727488A1 Tablet quickly disintegrating in the oral cavity and method for producing the same
12/17/2009CA2727432A1 Method for treating chronic wounds with an extracellular polymeric substance solvating system
12/17/2009CA2727389A1 5h-pyrrolo [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
12/17/2009CA2727373A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009CA2727326A1 Dronedarone for the prevention of permanent atrial fibrillation
12/17/2009CA2727319A1 Low dose topiramate/phentermine composition and methods of use thereof
12/17/2009CA2727317A1 Melanocortin receptor-specific peptides for treatment of sexual dysfunction
12/17/2009CA2727315A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents
12/17/2009CA2727313A1 Escalating dosing regimen for effecting weight loss and treating obesity
12/17/2009CA2727309A1 Novel embedment particles for inhalation
12/17/2009CA2727296A1 Compounds which can be used for the treatment of cancers
12/17/2009CA2727272A1 Composition for external use
12/17/2009CA2727245A1 Imidazole derivatives useful as inhibitors of faah
12/17/2009CA2727243A1 Branched 3- and 6-substituted quinolines as cgrp receptor antagonists
12/17/2009CA2727242A1 Pyrazole derivatives useful as inhibitors of faah
12/17/2009CA2727226A1 Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof
12/17/2009CA2727223A1 Human .beta.3 adrenergic receptor ligand, and food or pharmaceutical product containing the same
12/17/2009CA2727220A1 Method for producing a 1-biphenylmethylimidazole compound
12/17/2009CA2727210A1 Dronedarone for the prevention of cardioversion
12/17/2009CA2727196A1 Organic compounds
12/17/2009CA2727094A1 Unit dose formulations of ketorolac for intranasal administration
12/17/2009CA2727073A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009CA2727062A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
12/17/2009CA2727032A1 Novel tricyclic compounds
12/17/2009CA2727022A1 Rasagiline for parkinson's disease modification
12/17/2009CA2727019A1 Rasagiline soft gelatin capsules
12/17/2009CA2726666A1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
12/17/2009CA2726616A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
12/17/2009CA2726376A1 Substituted benzimidazoles for neurofibromatosis
12/17/2009CA2726158A1 Compounds and compositions useful for the treatment of malaria
12/17/2009CA2726114A1 Diazacarbazoles and methods of use
12/17/2009CA2726002A1 Process for the preparation of ezetimibe and composition containing it
12/17/2009CA2725755A1 Substituted pyrroles and methods of use
12/17/2009CA2725754A1 Diazacarbazoles and methods of use
12/17/2009CA2725654A1 Imidazolidine derivatives
12/17/2009CA2725482A1 Controlled release formulations of pramipexole
12/17/2009CA2725295A1 Combination of spacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine
12/17/2009CA2725093A1 Azacarboline derivatives, preparation method thereof and therapeutic us of same
12/17/2009CA2724919A1 Angiotensin ii receptor antagonists
12/17/2009CA2724516A1 Novel nucleic acid transfer system
12/17/2009CA2723998A1 Combination of a triptan and an nsaid
12/17/2009CA2723904A1 Novel modulators of sphingosine phosphate receptors
12/17/2009CA2723472A1 Compounds for rho kinase inhibition and for improving learning and memory
12/17/2009CA2722763A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
12/17/2009CA2721087A1 Anticancer methods using extracts of anemarrhena asphodeloides bunge
12/17/2009CA2720285A1 Pyrrolidine ether derivatives as nk3 receptor antagonists
12/17/2009CA2720254A1 Methods and compositions for the intracerebroventricular administration of felbamate
12/17/2009CA2716860A1 Compounds and method for reducing uric acid
12/16/2009WO2009154651A1 Treatment of metastic breast cancer by a combination of two anti-her2 antibodies and a taxene
12/16/2009EP2133428A1 New baculovirus vectors for improved protein production
12/16/2009EP2133353A1 Novel adenine compound
12/16/2009EP2133349A1 Kinase inhibitors
12/16/2009EP2133348A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
12/16/2009EP2133347A1 1-biarylazetidinone derivatives
12/16/2009EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof
12/16/2009EP2133340A1 Novel benzazepine derivatives
12/16/2009EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
12/16/2009EP2133338A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
12/16/2009EP2133337A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
12/16/2009EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
12/16/2009EP2133334A1 Heterocyclic derivatives as HDAC inhibitors
12/16/2009EP2133333A1 New azabicyclic derivatives, method of preparing same and pharmaceutical compositions containing them
12/16/2009EP2133332A1 (aza)indole derivative and use thereof for medical purposes
12/16/2009EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes
12/16/2009EP2133330A1 Atropisomer of pyrrole derivative
12/16/2009EP2133326A1 Novel pseudoglycolipid and use thereof
12/16/2009EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same
12/16/2009EP2133096A2 Oral disintegrating tablet
12/16/2009EP2133095A1 Pharmaceutical composition
12/16/2009EP2133094A1 Pharmaceutical composition
12/16/2009EP2133089A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
12/16/2009EP2133082A1 THE USE OF GINSENOSIDE Rg1, ITS METABOLITES GINSENOSIDE Rh1 AND PpT
12/16/2009EP2133081A1 RNAi modulation of the BCR-ABL fusion gene and uses thereof
12/16/2009EP2133080A1 Compounds containing equol
12/16/2009EP2133079A1 Compositions for the treatment of vaginal infections with chronic inflammation
12/16/2009EP2133078A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
12/16/2009EP2133077A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
12/16/2009EP2133076A1 Compositions for the treatment and prevention of infections of the oral cavity
12/16/2009EP2133075A1 Use of dronedarone for the preparation of a medicament intended for the prevention of cardioversion
12/16/2009EP2133074A1 Use of dronedarone for the preparation of a medicament intended for the prevention of permanent atrial fibrillation
12/16/2009EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
12/16/2009EP2133068A1 Method for selecting a suitable excipient for producing solid dispersions for pharmaceutical formulas
12/16/2009EP2133060A1 Process for producing preparation for oral administration
12/16/2009EP2132313A1 Inhibitors of mrp4 for the treatment of vascular disorders
12/16/2009EP2132228A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
12/16/2009EP2132216A1 Novel nucleoside analogs for treatment of viral infections
12/16/2009EP2132215A2 Compounds for preventing or treating viral infections and methods of use thereof
12/16/2009EP2132211A2 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
12/16/2009EP2132209A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
1 ... 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 ... 7860